RE;Spike. IMO27 Jun 2019 21:09
You have to bring Into the equation the people who bought In at £8. We're not speaking of any Tom,Dick or Harry (No offence to either). We're speaking about people that have history In Pharma. IMO, I feel that they were shocked at the PH111 trial failure. IMO, Results given during the week seems to back up their conviction of how effective that the compound IS. Markets are Not experts In Pharma. Markets are their to make money for Flippers, P+Ds, Investors and on Any Rumour, Sentiment, etc. BOD members paid £8 for what they thought was the value of the share at that stage, going on their previous experience In Pharma. The Co only got the news on the steroid negative over a month ago. So the Sp stated to rise when that news sunk In. As to the Confirmed news during the week that the steroid was the problem. IMO that news was seen as a negative rather than a confirmation on the steroid use negative. By whom for what reason?, I don't know. AIMOO.